Blackstone leading charge for Allscripts despite concerns over high premium

0
15

Global buyout heavyweight Blackstone has emerged as the frontrunner to buy Allscripts Healthcare Solutions, the healthcare technology company valued at $2bn.

The firm has beaten off private equity competition from Carlyle and TPG but is unsure of a deal given the high premium Allscripts is asking for, according to Reuters.

All three firms tabled second-round bids for the company in mid-November.

Allscripts’ shares fell 11 percent to $11.05 on the Nasdaq on Friday, down on the $10.88 close on September 27 – the day before news of a potential sale emerged, the report said.

First round bids were made in early October, with interest at that point also coming from Silver Lake Management.

Copyright © 2012 AltAssets